Deleted No
Hibernated Yes
Last Checked Aug. 26, 2021

Created

Thu Jul 08 20:15:00 +0000 2021

Likes

20

Retweets

6

Source

TweetDeck

View Raw Data

JSON Data

View on Twitter

Likely Available
Profile Image

Axios @axios

Biogen has modified the label of its new Alzheimer’s drug to narrow who should use it. The unusual move so soon after FDA approval raises questions about why it got approved for such a broad population in the first place. https://t.co/Q0b17FLwF8 — PolitiTweet.org

Posted July 8, 2021 Hibernated